Peiper M, Zurakowski D, Zornig C: Survival in primary soft tissue sarcoma of the extremities and trunk. Langenbecks Arch Chir 1997, 382: 203–208.
PubMed
CAS
Google Scholar
Peiper M, Zurakowski D, Schwarz R, Weh HJ, Zornig C: Survival in patients with primary soft-tissue sarcomas treated within 6 years. J Cancer Res Clin Oncol 1998, 124: 199–206. 10.1007/s004320050155
Article
PubMed
CAS
Google Scholar
Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Miyagi Y, Tsukuda M: Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 2004, 31: 35–41. 10.1016/j.anl.2003.09.005
Article
PubMed
Google Scholar
Nihei Z, Ichikawa W, Kojima K, Togo S, Miyanaga T, Hirayama R, Mishima Y: The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer. Surg Today 1996, 26: 760–761. 10.1007/BF00312104
Article
PubMed
CAS
Google Scholar
Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M: CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn J Cancer Res 1996, 26: 1265–1244.
Google Scholar
Stauder R, van Driel M, Schwarzler C, Thaler J, Lokhorst HM, Kreuser ED, Bloem AC, Günthert U, Eisterer W: Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996, 88: 3101–3108.
PubMed
CAS
Google Scholar
Goodison S, Urquidi V, Tarin D: CD44 cell adhesion molecules. Mol Pathol 1999, 52: 189–196. 10.1136/mp.52.4.189
Article
PubMed
CAS
PubMed Central
Google Scholar
Sugino T, Gorham H, Yoshida K, Bolodeoku J, Nargund V, Cranston D, Goodison S, Tarin D: Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996, 149: 873–882.
PubMed
CAS
PubMed Central
Google Scholar
Peiper M, Sato T, Zurakowski D, Eisenberger CF, Heinecke A, Hosch SB, Knoefel WT: CD44s expression is associated with improved survival in soft tissue sarcoma. Anticancer Res 2004, 24: 1053–1056.
PubMed
Google Scholar
Khan SA, Cook AC, Kappil M, Günthert U, Chambers AF, Tuck AB, Denhardt DT: Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis 2005, 22: 663–673. 10.1007/s10585-006-9007-0
Article
PubMed
CAS
Google Scholar
Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65: 13–24. 10.1016/0092-8674(91)90403-L
Article
PubMed
Google Scholar
Li Y, Heldin P: Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 2001, 85: 600–607. 10.1054/bjoc.2001.1922
Article
PubMed
CAS
PubMed Central
Google Scholar
Nguyen VN, Mirejovsky T, Melinova L, Mandys V: CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma 2000, 47: 400–408.
PubMed
CAS
Google Scholar
Forsberg UH, Ala-Kapee MM, Jalkanen S, Andersson LC, Schroder J: The gene for human lymphocyte homing receptor is located on chromosome 11. Eur J Immunol 1989, 19: 409–412. 10.1002/eji.1830190228
Article
PubMed
CAS
Google Scholar
Humphrey G, Hazel DL, MacLennan K, Lewis I: Expression of CD44 by rhabdomyosarcoma: a new prognostic marker? Br J Cancer 1999, 80: 918–921. 10.1038/sj.bjc.6690442
Article
PubMed
CAS
PubMed Central
Google Scholar
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 58: 457–481.
Article
Google Scholar
Cox DR: Regression models and life-tables (with discussion). J Royal Stat Soc 1972, 34: 187–220. Series B
Google Scholar
Terpe HJ, Christiansen H, Gonzalez M, Berthold F, Lampert F: Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 1995, 31A: 549–552.
Article
PubMed
CAS
Google Scholar
Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T: Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 2000, 46: 14–19. 10.1136/gut.46.1.14
Article
PubMed
CAS
PubMed Central
Google Scholar
Kuryu M, Ozaki T, Nishida K, Shibahara M, Kawai A, Inoue H: Expression of CD44 variants in osteosarcoma. J Cancer Res Clin Oncol 1999, 125: 646–652. 10.1007/s004320050329
Article
PubMed
CAS
Google Scholar
Yoo CH, Noh SH, Kim H, Lee HY, Min JS: Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol 1999, 71: 22–28. 10.1002/(SICI)1096-9098(199905)71:1<22::AID-JSO5>3.0.CO;2-I
Article
PubMed
CAS
Google Scholar
Kahara N, Ozaki T, Doi T, Nishida K, Kawai A, Shibahara M, Inoue H: CD44 expression in soft tissue sarcomas. Virchows Arch 2000, 436: 574–578. 10.1007/s004289900159
Article
PubMed
CAS
Google Scholar
Maula S, Huuhtanen RL, Blomqvist CP, Wiklund TA, Laurila P, Ristamaki R: The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas. Br J Cancer 2001, 84: 244–252. 10.1054/bjoc.2000.1590
Article
PubMed
CAS
PubMed Central
Google Scholar
Hashii K, Tohya K, Kimura M, Tateyama I, Mori T, Kadota E, Hashimoto S, Tomura T: Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells. Invasion Metastasis 1997, 17: 149–157.
PubMed
CAS
Google Scholar
Nilbert M, Alveg R, Thor A, Rydholm A, Weide J, Bjerkehagen P, Domanski B, Henryk A, Kerman P, Bendahl P, Persson A, Engellau J: Expression profiling using tissue microarray in 211malignant fibrous histiocytomas confirms the prognostic value of Ki-67. Virchows Arch 2004, 445: 224–230. 10.1007/s00428-004-1065-6
Article
PubMed
Google Scholar
Iida N, Bourguignon LY: New CD44 splice variant associated with human breast cancers. J Cellular Physiol 1995, 112: 127–133.
Article
Google Scholar
Niu Y, Liu F, Zhou Z, Wang H: Expression of CD44v6 and PCNA in squamous cell carcinomas. Chinese Med J 2002, 115: 1564–1568.
CAS
Google Scholar
Yang K, Tang Y, Habermehl GK, Iczkowski KA: Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer 2010, 10: 16. 10.1186/1471-2407-10-16
Article
PubMed
PubMed Central
Google Scholar
Miettinen M: Diagnostic soft tissue pathology. 1st edition. Philadelphia: Churchill Livingstone; 2003.
Google Scholar